Different immune responses to the pathological therapeutic effect of neoadjuvant chemotherapy in the tumor microenvironment of locally-advanced breast cancer

被引：0
|
作者：
Kim, R. [1 ]
Kawai, A. [1 ]
Wakisaka, M. [1 ]
Sawada, S. [1 ]
Shimoyama, M. [1 ]
Yasuda, N. [1 ]
Hidaka, M. [2 ]
Morita, Y. [2 ]
Ohtani, S. [3 ]
Arihiro, K. [4 ]
机构：
[1] Hiroshima Mark Clin, Hiroshima, Japan
[2] Genet Testing Gene Res, Hiroshima, Japan
[3] Hiroshima City Hosp, Hiroshima, Japan
[4] Hiroshima Univ Hosp, Hiroshima, Japan
来源：
BREAST | 2019年 / 44卷
关键词：
D O I：
10.1016/S0960-9776(19)30265-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P164
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [21] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Mónica Fernández-Sánchez
    Armando Gamboa-Dominguez
    Norma Uribe
    Ana Cristina García-Ulloa
    Diana Flores-Estrada
    Myrna Candelaria
    Oscar Arrieta
    Medical Oncology, 2006, 23 : 171 - 183
  • [22] The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy
    Claudia Urueña
    Paola Lasso
    David Bernal-Estevez
    Diego Rubio
    Ana Janeth Salazar
    Mercedes Olaya
    Alfonso Barreto
    Mauricio Tawil
    Lilian Torregrosa
    Susana Fiorentino
    Scientific Reports, 12
  • [23] The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy
    Uruena, Claudia
    Lasso, Paola
    Bernal-Estevez, David
    Rubio, Diego
    Salazar, Ana Janeth
    Olaya, Mercedes
    Barreto, Alfonso
    Tawil, Mauricio
    Torregrosa, Lilian
    Fiorentino, Susana
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Factors Required for Individual Immune Responses to Achieve Pathological and Therapeutic Effects of Neoadjuvant Chemotherapy in Breast Cancer Patients
    Kim, Ryungsa
    Kawai, Ami
    Wakisaka, Megumi
    Sawada, Sayaka
    Shimoyama, Mika
    Yasuda, Naomi
    Hidaka, Masayuki
    Morita, Yukitaka
    Ohtani, Shoichiro
    Arihiro, Koji
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S621 - S622
  • [25] Response rate with weekly epirubicin and docetaxel as neoadjuvant chemotherapy (NAC) for locally-advanced breast cancer (BC).
    Chen, SC
    Chang, HK
    Lin, YC
    Leung, WM
    Chang, JT
    Cheung, YC
    Hsueh, S
    Lo, YF
    Tsai, HP
    Chen, MF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 99S - 99S
  • [26] Effects of neoadjuvant chemotherapy on immune microenvironment and clinical outcomes in locally advanced gastric cancer.
    Yu, Yue
    Zeng, Yi-Xin
    Zhou, Ai-Ping
    Ma, Xiaopeng
    Zhang, Yun
    Shen, Zhirong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Do responses in PET/CT correlate with pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer?
    Kaya, Serap
    Simsek, Eda Tanrikulu
    Ugurlu, Umit
    Ozgen, Zerrin
    Halil, Suleyman
    Besiroglu, Mehmet
    Koca, Sinan
    Babacan, Nalan
    Dane, Faysal
    Kaya, Handan
    Turhal, Serdar
    Yumuk, Fulden
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Neoadjuvant chemotherapy for male with locally advanced breast cancer
    Murashko, R.
    Keshabyan, A.
    Zandaryan, A.
    Stepanov, A.
    BREAST, 2019, 44 : S69 - S69
  • [30] Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer
    Ge Ma
    Jingyi Wang
    Jingyue Fu
    Rui Chen
    Mengdi Liang
    Minghui Li
    Tiansong Xia
    Xiaoan Liu
    Shui Wang
    Breast Cancer Research and Treatment, 2023, 201 : 27 - 41
12345